Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virusReview Published on 2023-04-012023-05-31 Journal: Expert opinion on pharmacotherapy [Category] [DOI] 10.1080/14656566.2023.2195050 PMC 바로가기 [Article Type] Review
Herpes zoster in patients with inflammatory arthritides or ulcerative colitis treated with tofacitinib, baricitinib or upadacitinib: a systematic review of clinical trials and real-world studiesArticle Published on 2023-03-012023-06-01 Journal: Rheumatology International [Category] [DOI] 10.1007/s00296-022-05270-6 PMC 바로가기
The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysisMeta-Analysis Published on 2022-12-012023-06-01 Journal: European Journal of Clinical Pharmacology [Category] [DOI] 10.1007/s00228-022-03400-4 PMC 바로가기 [Article Type] Meta-Analysis
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyArticle Published on 2022-11-012022-11-15 Journal: The Lancet. Gastroenterology & Hepatology [Category] [DOI] 10.1016/S2468-1253(22)00274-6 PMC 바로가기
JAK kinase inhibitors and varicella zoster virus infection in patients with rheumatoid arthritis. Systematic review of the literatureArticle Published on 2022-10-012023-06-01 Journal: Reumatología clinica [Category] [DOI] 10.1016/j.reumae.2021.06.001 PMC 바로가기
Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis류마티스 관절염 환자에서 SARS-CoV-2 백신 접종에서 BNT162b2 mRNA를 포함한 부스터의 역할Article Published on 2022-08-012022-09-12 Journal: Immunologic research [Category] [DOI] 10.1007/s12026-022-09283-y PMC 바로가기 [Article Type] Article
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy면역억제 요법을 받는 환자에서 표준 및 3차 접종 SARS-CoV-2 백신 접종의 면역원성과 안전성Observational Study Published on 2022-08-012022-09-12 Journal: Arthritis & rheumatology (Hoboken, N.J.) [Category] [DOI] 10.1002/art.42153 PMC 바로가기 [Article Type] Observational Study
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysisCOVID-19로 병원에 입원한 환자의 바리시티닙(RECOVERY): 무작위, 통제, 공개 라벨, 플랫폼 시험 및 업데이트된 메타 분석Meta-Analysis Published on 2022-07-302022-09-11 Journal: Lancet (London, England) [Category] [DOI] 10.1016/S0140-6736(22)01109-6 PMC 바로가기 [Article Type] Meta-Analysis
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort염증성 류마티스 질환 환자에서 BNT162b2 Anti-SARS-CoV-2 백신 접종에 대한 혈청학적 반응: RHEUVAX 코호트의 결과Article Published on 2022-06-172022-09-12 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.901055 PMC 바로가기 [Article Type] Article
JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoidsJAK 억제제는 사구체 세포에서 COVID-19 사이토카인 유도 JAK/STAT/APOL1 신호전달 및 인간 신장 오르가노이드에서 족세포병증을 차단합니다Article Published on 2022-06-082022-09-11 Journal: JCI Insight [Category] [DOI] 10.1172/jci.insight.157432 PMC 바로가기 [Article Type] Article